In NSCLC, two potential LINC00511 targets, enhancer zeste homolog 2 (EZH2) and lysine-specific demethylase 1 (LSD1), have been verified [42, 43]. This evidence concerns the gene LINC00511 and non-small cell lung carcinoma.